7Baggers
Quarterly
Annual
    Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 
      
    		                           
      operating activities
    		                           
      net income
    		20,390,000 -39,328,000 -31,594,000 -34,655,000 -85,571,000 -45,492,000 -43,008,000 -46,243,000 -57,395,000 -59,156,000 -41,824,000 -51,115,000 -60,517,000 -60,668,000 -45,563,000 -41,242,000 -40,037,000 -37,919,000 -32,900,000 -24,318,000 -28,207,000 -31,768,000 -55,638,000 -31,181,000 -27,916,000 -25,933,000 -22,639,000 
      adjustments to reconcile net income to net cash from operating activities
    		                           
      depreciation and amortization expense
    		                           
      impairment of long-lived assets
    		   0                        
      stock-based compensation expense
    		                           
      gain on sale of business
    		                           
      other non-cash adjustments
    		1,152,000 831,000 -20,000 1,179,000 -478,000                       
      changes in assets and liabilities:
    		                           
      accounts receivable, net [1]
    		                           
      inventories
    		-5,078,000 2,657,000 560,000 4,408,000 1,891,000 486,000 1,201,000 4,289,000 3,555,000 4,675,000 -5,281,000 3,701,000 1,550,000 -4,351,000 -8,436,000 -10,575,000 -5,370,000 -2,422,000 -1,122,000 875,000 -2,398,000 -3,347,000 -86,000 -1,834,000 -1,047,000   
      prepaid expenses and other current assets [2]
    		                           
      other non-current assets
    		19,000 -266,000 -356,000 -41,000 163,000 9,000 300,000 326,000 -156,000 707,000 499,000 444,000 2,956,000 642,000 3,231,000 -2,320,000 -2,246,000 -146,000 59,000 -130,000 -228,000 -258,000 62,000 -1,622,000 -251,000 201,000 -392,000 
      accounts payable
    		3,194,000 711,000 5,711,000 -4,878,000 -1,202,000 -1,520,000 -4,205,000 1,923,000 -220,000 -7,493,000 3,282,000 6,917,000 1,228,000 -757,000 -5,000 3,348,000 1,396,000 339,000 3,459,000 -1,691,000 -740,000 -2,519,000 -556,000 3,374,000 1,921,000 -1,302,000 -715,000 
      accrued expenses
    		158,000 139,000 3,137,000 283,000 273,000 959,000 2,900,000 1,300,000 -1,615,000 4,147,000 -1,254,000 1,661,000 -1,277,000 1,440,000 445,000 1,569,000 1,591,000 104,000 -149,000 714,000 -325,000 -1,758,000 -1,279,000 2,249,000 1,303,000 619,000 39,000 
      accrued compensation
    		3,966,000 3,192,000 -11,850,000 1,943,000 6,471,000 4,539,000 -5,078,000 -1,447,000 3,050,000 1,014,000 -3,716,000 -667,000 6,172,000 2,971,000 -3,624,000 2,804,000 4,626,000 3,319,000 -3,357,000 3,633,000 2,680,000 -219,000 -1,629,000     
      other liabilities[3]
    		                           
      net cash from operating activities
    		-1,400,000 -12,986,000 -21,428,000 -15,320,000 -6,378,000 -19,423,000 -22,973,000 -20,704,000 -23,412,000 -44,288,000 -54,070,000 -1,267,000 -34,125,000 -42,340,000 -46,653,000 -34,803,000 -27,960,000 -24,549,000 -24,932,000 -25,202,000 -23,468,000 -58,671,000 -34,914,000 -23,358,000 -22,082,000 -20,813,000 -21,684,000 
      capex
    		-9,165,000 -4,144,000 -2,268,000 -2,002,000 -965,000 -603,000 -1,506,000 -2,393,000 -4,509,000 -9,053,000 -11,824,000 -16,462,000 -40,642,000 -31,970,000 -12,783,000 -8,089,000 -6,942,000 -8,401,000 -3,629,000 -2,225,000 -2,848,000 -2,737,000 -2,058,000 -3,893,000 -5,172,000 -3,770,000 -1,922,000 
      free cash flows
    		-10,565,000 -17,130,000 -23,696,000 -17,322,000 -7,343,000 -20,026,000 -24,479,000 -23,097,000 -27,921,000 -53,341,000 -65,894,000 -17,729,000 -74,767,000 -74,310,000 -59,436,000 -42,892,000 -34,902,000 -32,950,000 -28,561,000 -27,427,000 -26,316,000 -61,408,000 -36,972,000 -27,251,000 -27,254,000 -24,583,000 -23,606,000 
      investing activities
    		                           
      purchases of property and equipment
    		-9,165,000 -4,144,000 -2,268,000 -2,002,000 -965,000 -603,000 -1,506,000 -2,393,000 -4,509,000 -9,053,000 -11,824,000 -16,462,000 -40,642,000 -31,970,000 -12,783,000 -8,089,000 -6,942,000 -8,401,000 -3,629,000 -2,225,000 -2,848,000 -2,737,000 -2,058,000 -3,893,000 -5,172,000 -3,770,000 -1,922,000 
      purchases of investments
    		-2,732,000 -4,932,000 -20,593,000 -21,193,000 -1,746,000 -10,637,000 -18,329,000 -18,090,000 -7,821,000 -27,787,000 -22,647,000 0 0 0 -217,639,000 0 0 15,497,000 -74,292,000 -92,444,000 -103,901,000 0 -6,537,000 -40,310,000 -50,639,000 -22,790,000 -63,835,000 
      proceeds from maturity of investments
    		0 7,650,000 21,325,000 21,910,000 2,000,000 6,000,000 24,000,000 18,236,000 31,000,000 78,000,000 27,500,000 25,000,000 44,805,000 18,676,000 12,000,000 32,000,000 112,000,000 66,494,000 32,000,000  45,600,000 31,500,000 21,000,000  33,100,000   
      proceeds from sale of business
    		                           
      net cash from investing activities
    		-9,397,000 -1,426,000 -1,536,000 -1,285,000 -711,000 -5,240,000 4,165,000 -2,247,000 18,670,000 41,160,000 -6,971,000 2,783,000 4,163,000 -13,294,000 -226,582,000 23,911,000 104,575,000   -94,669,000 -61,149,000 28,763,000 12,405,000 -1,187,000 -22,706,000 -15,160,000 -65,757,000 
      financing activities
    		                           
      proceeds from exercise of stock options
    		1,829,000 772,000 2,950,000 1,917,000 2,915,000 1,317,000 951,000 171,000 353,000 251,000 604,000 1,250,000 764,000 895,000 3,105,000 2,873,000 2,570,000 3,032,000 6,084,000 5,518,000 1,916,000 1,387,000 1,674,000     
      proceeds from the issuance of liability related to sale of future revenue
    		0 0 15,000,000                         
      proceeds from issuance of common stock under employee stock purchase plan
    		0    0    0    -1,000    0    0       
      repurchases of common stock for income tax withholding
    		-3,000 -5,000 -6,000 -8,000 -7,000 -1,536,000 -2,424,000 -1,130,000 -1,014,000 -1,262,000 -999,000 -1,624,000 -2,080,000 -1,492,000 -2,558,000 -2,622,000 -2,476,000 -3,341,000 -2,410,000 -773,000 -450,000 -390,000 -808,000     
      net cash from financing activities
    		1,826,000 3,196,000 17,944,000 3,627,000 2,908,000 1,828,000 -1,473,000 442,000 -661,000 1,525,000 -395,000 1,240,000 -1,311,000 271,616,000 -1,011,000 1,575,000 -765,000 1,451,000 326,921,000 5,574,000 108,064,000 188,037,000 2,057,000 2,928,000 84,285,000 -1,634,000 72,999,000 
      effect of exchange rates on cash, cash equivalents and restricted cash
    		-71,000 104,000 -53,000 73,000 2,000 -65,000 116,000 -48,000 -320,000 73,000 268,000 -318,000 -105,000 21,000 83,000 -133,000 100,000 48,000 5,000 27,000 12,000 -27,000 9,000     
      net decrease in cash, cash equivalents, and restricted cash
    		-9,042,000 -11,112,000 -5,073,000  -4,179,000 -22,900,000 -20,165,000   -1,530,000 -61,168,000            -20,443,000    -14,442,000 
      cash, cash equivalents, and restricted cash at beginning of period
    		0 0 229,132,000  0 0 289,281,000  0 0 380,259,000  0 0 467,359,000  0 0 94,246,000  0 0 47,398,000  0 0 81,537,000 
      cash, cash equivalents, and restricted cash at end of period
    		-9,042,000 -11,112,000 224,059,000  -4,179,000 -22,900,000 269,116,000  -5,723,000 -1,530,000 319,091,000  -31,378,000 216,003,000 193,196,000  75,950,000 50,540,000 350,319,000  23,459,000 158,102,000 26,955,000  39,497,000 -37,607,000 67,095,000 
      depreciation and amortization
    		 6,404,000 6,380,000 6,656,000 8,301,000 8,304,000 8,171,000 8,500,000 8,490,000 7,028,000 5,292,000 4,952,000 4,444,000 3,968,000 3,150,000 2,431,000 2,744,000 2,464,000 2,111,000 1,889,000 1,724,000 1,559,000 1,505,000 1,489,000 1,587,000 1,563,000 1,472,000 
      stock-based compensation
    		 20,328,000 11,991,000 12,347,000 13,734,000 13,824,000 11,020,000 11,747,000 10,597,000 10,259,000 -2,325,000 19,048,000 20,043,000 22,465,000 18,108,000 9,247,000 9,176,000 11,553,000 7,022,000 5,131,000 4,071,000 4,197,000 3,697,000 3,363,000 3,032,000 2,911,000 1,864,000 
      accounts receivable
    		 -10,722,000 -4,537,000 -2,954,000 3,997,000 -657,000 8,058,000 -1,812,000 5,542,000 -3,952,000 -4,098,000 662,000 -6,439,000 -1,813,000 -2,032,000 -290,000 -581,000 -2,215,000 884,000 -13,029,000 1,484,000 -1,777,000 -950,000 -577,000 -3,529,000 -1,020,000 -1,559,000 
      prepaid expenses and other current assets
    		 1,133,000 -249,000 567,000 235,000 696,000 -1,116,000 -2,231,000 -344,000 -414,000 -1,177,000 185,000 -1,329,000 -1,316,000 -91,000 -441,000 1,114,000 -688,000 -2,043,000 31,000 -1,761,000 964,000 -2,917,000 868,000 609,000 -365,000 -366,000 
      other liabilities
    		 1,935,000 -601,000 -468,000 734,000 -1,055,000 -1,528,000 -1,907,000 2,203,000 -530,000 126,000 -10,378,000 2,122,000 866,000 -34,000 1,919,000 -3,073,000 449,000 677,000 1,402,000 1,177,000 -790,000 189,000 108,000 -102,000 -388,000 135,000 
      supplemental disclosure of cash flow information
    		                           
      income taxes paid, net of refunds
    		 13,000 3,000 -19,000 24,000 299,000 40,000 179,000 104,000 85,000 52,000 116,000 0 39,000 91,000 54,000 46,000 -80,000 81,000 52,000 0 76,000 44,000 70,000 60,000 108,000 53,000 
      non-cash investing and financing activities
    		                           
      property and equipment additions included in accounts payable and accrued expenses
    		 -807,000 2,136,000  177,000 -438,000 487,000  -61,000 -2,773,000 4,520,000  -2,175,000 -2,742,000 11,479,000  1,580,000 -1,318,000 1,515,000  -752,000 708,000 66,000  1,087,000 -931,000 1,117,000 
      property and equipment capitalized acquired through tenant improvement allowance
    		                           
      cash flows from operating activities
    		                           
      cash flows from investing activities
    		                           
      cash flows from financing activities
    		                           
      non-cash lease expense, net of tenant improvement allowance
    		                           
      change in fair value of contingent considerations and holdbacks
    		                           
      gain on deconsolidation of revelar
    		                           
      business acquisition, net of cash acquired
    		           0 0 0 -8,160,000 0            
      deconsolidation of cash and cash equivalent relating to revelar
    		                           
      proceeds from public offerings, net of underwriting discounts, commissions and offering expenses
    		           -2,000 6,000           0    
      proceeds from issuance under employee stock purchase plan
    		                           
      repayments of long-term debt
    		           0 0     -834,000 -833,000 -833,000 -833,000 -834,000 -833,000     
      net increase in cash, cash equivalents and restricted cash
    		                           
      cash, cash equivalents, and restricted cash at beginning of year
    		                           
      cash, cash equivalents, and restricted cash at end of year
    		                           
      interest paid
    		           0 0 0 9,000 22,000 36,000 48,000 61,000 75,000 92,000 125,000 146,000 174,000 192,000 206,000 207,000 
      property and equipment additions included in accrued expenses and accounts payable
    		                           
      operating lease right-of-use assets obtained in exchange for operating lease liabilities
    		       2,461,000    1,873,000 0 9,071,000 10,423,000 0 33,554,000   0 885,000 0 2,833,000     
      issuance of common stock in connection with the business acquisition
    		       0 1,768,000   0 0 4,608,000 72,514,000             
      tenant improvement allowance capitalized in property and equipment
    		   0 0                       
      conversion of convertible notes
    		       0                    
      non-cash lease expense
    		    144,000 255,000 248,000  454,000 332,000 254,000  985,000 435,000 1,174,000 1,199,000 830,000 -34,000 248,000 196,000 -1,012,000 -463,000 236,000     
      change in fair value of acquisition consideration
    		        -582,000 -1,196,000 -4,135,000                 
      other non cash adjustments
    		      64,000   291,000 287,000                 
      impairment of property and equipment and other assets
    		       3,165,000                    
      deferred tax liability
    		            -132,000 -500,000 -10,545,000             
      other non cash adjustment
    		                           
      net increase in cash, cash equivalents, and restricted cash
    		            -31,378,000 216,003,000 -274,163,000  75,950,000 50,540,000 256,073,000  23,459,000    39,497,000   
      proceeds from (repayments of) long-term debt
    		              -1,558,000             
      loss on disposal of property and equipment
    		               0 0 0 2,000     -13,000 194,000 0 8,000 
      discount (premium) accretion on investment securities
    		               92,000 187,000           
      realized gain on investments
    		               0 -1,000           
      allowance for doubtful accounts
    		                           
      non-cash interest expense
    		           0 0 0 3,000 9,000 14,000 19,000 25,000 30,000 35,000 41,000 46,000 51,000 57,000 61,000 64,000 
      amortization of debt discount
    		           0 0 0 4,000 11,000 17,000 23,000 30,000 36,000 43,000 49,000 56,000 63,000 67,000 74,000 78,000 
      write off property and equipment
    		           0 0               
      discount accretion on investment securities
    		            266,000 472,000 318,000    122,000 29,000 -11,000 -82,000 -150,000 -281,000 -447,000   
      bad debt expense
    		            34,000               
      contingent consideration and holdbacks
    		                           
      change in fair value of contingent consideration and indemnity holdback
    		              -2,826,000             
      unrealized currency translation
    		              70,000             
      deferred offering costs included in accounts payable and accrued expenses
    		                  229,000       -806,000 826,000 
      proceeds from sale of property and equipment
    		                       16,000    
      conversion of redeemable convertible preferred stock warrant liability to equity
    		                       0 0 0 631,000 
      conversion of redeemable convertible preferred stock to common stock
    		                       0 0 0 290,462,000 
      issuance of common stock in connection with the igenomx acquisition
    		               0            
      bad debts expense
    		                           
      changes in assets and liabilities, net of acquisition:
    		                           
      proceeds from public offerings, net of underwriting discounts and commissions and offering expenses
    		                -26,000    107,431,000       
      repayments of debt
    		                           
      offering expenses included in accounts payable and accrued expenses
    		                    -76,000       
      accrued litigation settlement
    		                      22,500,000     
      net cash (used in) / provided by investing activities
    		                  -45,921,000         
      proceeds from public offering, net of underwriting discounts and commissions and offering expenses
    		                  324,080,000    2,024,000     
      change in fair value of redeemable convertible preferred stock warrant liability
    		                           
      maturity of investments
    		                           
      proceeds from issuance of series d redeemable convertible preferred stock, net of issuance costs
    		                           
      payments of deferred offering costs
    		                           
      borrowings of long-term debt
    		                           
      fair value of warrants issued in connection with debt
    		                           
      accrued payroll
    		                        2,440,000 2,175,000 -140,000 
      proceeds from issuance of common stock and exercise of stock options
    		                        864,000 25,000 220,000 
      principal repayment on long term debt
    		                        -834,000   
      proceeds from initial public offering, net of underwriting discounts, commissions and offering expenses
    		                         -826,000 72,779,000 
      changes in assets and liabilities, net of impact of business combination:
    		                           
      inventory
    		                          467,000 
      change in restricted cash
    		                           
      cash acquired through business combination
    		                           
      net increase in cash and cash equivalents
    		                           
      cash and cash equivalents at beginning of year
    		                           
      cash and cash equivalents at end of year
    		                           
      fair value of common stock issued to owners of genome compiler corporation
    		                           
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.